Results 331 to 340 of about 11,447,845 (407)

Herb-Drug Interaction Between Sailuotong and Pitavastatin: A Systematic Pharmacokinetic Investigation and Mechanism Analysis. [PDF]

Drug Des Devel Ther
Zhang Y, Yi H, Yang H, Song Y, Ren C, Li X, Zhang Y.   +6 more
europepmc   +1 more source

A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell–scaffold interaction and chemotherapeutic resistance of anticancer drugs

, 2011
Zehong Yang, Xiaojun Zhao
openalex   +1 more source

Drug-drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450. [PDF]

Br J Clin Pharmacol
Purohit VS, Huh Y, Dowty ME, Plotka A, Lejeune A, Kalluru H, Hee B.   +6 more
europepmc   +1 more source

2D interaction of compound 6e (left) and indomethacin drug (right) within the active site of cyclooxygenase-1 (COX-1) (PDB ID: 1EQG).

Yasser Hussein Issa Mohammed (17140711), Ahmed Hassen Shntaif (22320292), Saad Alghamdi (362506), Ahd A. Mansour (21660692), Naeem F. Qusty (15416890), Azhar S. Sindi (13259916), Ahmad O. Babalghith (15279713), Ghazi A. Bamagous (22320295), Eman Adnan Abu-Seer (22320298)   +8 more
openalex   +1 more source

Part 1: Evaluation of Pediatric Cannabis-Drug Interaction Reports. [PDF]

Pharmacol Res Perspect
Chapin MR, Kane-Gill SL, Li X, Abanyie K, Taneja SB, Egbert S, Paine MF, Boyce RD.   +7 more
europepmc   +1 more source

HCLOT for drug-microbe interaction prediction

Yuanyuan Ma
openalex   +1 more source

A theoretical model for detecting drug interaction with awareness of timing of exposure. [PDF]

Sci Rep
Shi Y, Sun A, Yang Y, Xu J, Li J, Eadon M, Su J, Zhang P.   +7 more
europepmc   +1 more source

Concerns on Drug Interactions between Proton Pump Inhibitors and Clopidogrel: Unsafe Perspective

, 2011
Kyounghoon Lee, Seung Hwan Han
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

SSI-DDI: substructure-substructure interactions for drug-drug interaction prediction

Briefings Bioinform., 2021
A major concern with co-administration of different drugs is the high risk of interference between their mechanisms of action, known as adverse drug-drug interactions (DDIs), which can cause serious injuries to the organism.
Arnold K. Nyamabo, Hui Yu, Jian-Yu Shi
semanticscholar   +1 more source